Similar articles

• Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.

  Chen NF, Smith ZA, Stiner E, Armin S, Sheikh H, Khoo LT. Chen NF, et al. J Neurosurg Spine. 2010 Jan;12(1):40-6. doi: 10.3171/2009.4.SPINE0876. J Neurosurg Spine. 2010. PMID: 20043763
• Symptomatic ectopic intracanal ossification after transforaminal lumbar interbody fusion with rhBMP-2.

  Lehman RA Jr, Kang DG. Lehman RA Jr, et al. Spine J. 2012 Jun;12(6):530-1. doi: 10.1016/j.spinee.2012.05.005. Epub 2012 Jun 7. Spine J. 2012. PMID: 22682741 No abstract available.
• Heterotopic ossification associated with recombinant human bone morphogenetic protein-2 (infuse) in posterolateral lumbar spine fusion: a case report.

  Anderson CL, Whitaker MC. Anderson CL, et al. Spine (Phila Pa 1976). 2012 Apr 15;37(8):E502-6. doi: 10.1097/BRS.0b013e318238870b. Spine (Phila Pa 1976). 2012. PMID: 22020605
• Complications Associated With Bone Morphogenetic Protein in the Lumbar Spine.

  Kang DG, Hsu WK, Lehman RA Jr. Kang DG, et al. Orthopedics. 2017 Mar 1;40(2):e229-e237. doi: 10.3928/01477447-20161213-06. Epub 2016 Dec 20. Orthopedics. 2017. PMID: 27992640 Review.
• Complications associated with posterior and transforaminal lumbar interbody fusion.

  Chrastil J, Patel AA. Chrastil J, et al. J Am Acad Orthop Surg. 2012 May;20(5):283-91. doi: 10.5435/JAAOS-20-05-283. J Am Acad Orthop Surg. 2012. PMID: 22553100 Review.